10 likes | 108 Vues
Research on the use of Tat-NR2B9c treatment in non-human primates undergoing MCAO showed significant reduction in infarct volume. Findings, published in Nature, indicate potential neuroprotection in stroke.
E N D
Treatment with Tat-NR2B9c attenuates infarct volume in NHPs subjected to MCAO(—)p DJ Cook et al. Nature000, 1-5 (2012) doi:10.1038/nature10841